Abrdn PLC Eye Point Pharmaceuticals, Inc. Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Abrdn PLC holds 1,031,201 shares of EYPT stock, worth $10.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,031,201
Previous 230,745
346.9%
Holding current value
$10.9 Million
Previous $1.25 Million
676.24%
% of portfolio
0.02%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EYPT
# of Institutions
165Shares Held
72.4MCall Options Held
232KPut Options Held
207K-
Cormorant Asset Management, LP Boston, MA8.33MShares$88.1 Million4.79% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$72 Million1.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.2MShares$65.6 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA4.15MShares$43.9 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.09MShares$43.2 Million0.05% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $360M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...